Person

Nicole Murphy

Head of Pharm Ops and Tech, Biogen

Current S&P 500 boards
0
Current roles
1
Open-market buys
$585
Open-market sales
$0

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

  • BIIB
    Biogen
    Head of Pharm Ops and Tech
    since Feb 2022

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 12, 2026BIIBBuy3$195.04$585

SEC reporting-owner ID (CIK) 1910644 · all filings on EDGAR